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Abstract
Background: Prevention of cardiovascular diseases (CVD) is a major health issue worldwide. Primary care plays an
important role in cardiovascular risk management (CVRM). Guidelines and quality of care measures to assess CVRM
in primary care practices are available. In this study, we assessed the relationship between structural and
organisational practice characteristics and the quality of care provided in individuals at high risk for developing CVD
in European primary care.
Methods: An observational study was conducted in 267 general practices from 9 European countries. Previously
developed quality indicators were abstracted from medical records of randomly sampled patients to create a
composite quality measure. Practice characteristics were collected by a practice questionnaire and face to face
interviews. Data were aggregated using factor analysis to four practice scores representing structural and
organisational practice features. A hierarchical multilevel analysis was performed to examine the impact of practice
characteristics on quality of CVRM.
Results: The final sample included 4223 individuals at high risk for developing CVD (28% female) with a mean age of
66.5 years (SD 9.1). Mean indicator achievement was 59.9% with a greater variation between practices than between
countries. Predictors at the patient level (age, gender) had no influence on the outcome. At the practice level, the score
‘Preventive Services’ (13 items) was positively associated with clinical performance (r = 1.92; p = 0.0058). Sensitivity analyses
resulted in a 5-item score (PrevServ_5) that was also positively associated with the outcome (r = 4.28; p < 0.0001).
Conclusions: There was a positive association between the quality of CVRM in individuals at high risk for developing CVD
and the availability of preventive services related to risk assessment and lifestyle management supported by information
technology.
Background
Cardiovascular diseases (CVD) are major causes of mor-
bidity and mortality across developed countries worldwide
and contribute substantially to escalating healthcare costs
[1,2]. Therefore, prevention of cardiovascular disease is a
priority for health care systems in most countries [3].
Patients should receive or be offered a range of appro-
priate services in primary care to address their acute and
chronic conditions, including health promotion and
targeted lifestyle advice [4]. Lifestyle advice by general
practitioners to individuals takes place alongside commu-
nity or population level health promotion initiatives
designed to improve the overall health of populations [5].
However, the delivery of preventive services is often a
low priority in family practices [6]. It has been stated that
practice systems and processes are not optimally designed
to address the care of individuals with preventive needs,
for instance the delivery of behavioural counselling [7,8].
Despite various approaches to improve structure and or-
ganisation of services delivered in primary care [9,10] little
is known about the relationship between structural and
organisational practice characteristics and the quality of
care [11], especially as it relates to preventive care. It has
been shown that some practice capabilities such as the use
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of electronic health records were associated with improved
clinical performance [12]. The National Committee for
Quality Assurance (NCQA) defined structural elements in
practices with a focus on information technology to quality
practices as medical homes according to the patient-
centred medical home model [13]. However, key relation-
ships between structural capabilities of practices and their
performance on measures of clinical quality in routine pri-
mary care settings have not been clearly detected [12,13].
The aim of this study was to determine the effect of
structural and organisational practice characteristics on
the quality of preventive care for patients at high risk for
developing CVD in routine primary care within different
European health care systems.
Methods
This study was part of the European Practice assessment
(EPA) - Cardio project (2006–2010), which focused on
the assessment of cardiovascular risk management in
European primary care in populations at different risk
levels. In the first stage of the project we developed
quality indicators to measure cardiovascular prevention
and care [14] and identified additional measures that
were piloted before being used in this study [15].
Samples
This cross-sectional observational study was conducted
between 2008 and 2009 and involved ten European
countries: Austria, Belgium, Finland, France, Germany,
the Netherlands, Slovenia, Spain, Switzerland and the
United Kingdom (UK). In this part of the study, Finland
was excluded due to insufficient practice data (Figure 1).
The study design and data collection methods have been
published in detail elsewhere [15,16]. In order to achieve
a predefined degree of statistical accuracy a representa-
tive sample of 36 general practices per country was
aimed for. Each practice had to identify patients at high
risk for CVD from the practice register according to the
criteria listed in Table 1. Of the eligible patients, a sam-
ple of 30 patients per practice was randomly selected to
be posted a questionnaire and informed written consent
form, with the aim of recruiting at least 15 patients per
practice. The study was approved by relevant ethics
committees in all participating countries.
Measures
The main outcome measure was the quality of cardio-
vascular risk management (CVRM) that was measured
against eleven quality indicators developed in the earlier
stage of the EPA-Cardio project [14]. These indicators
were related to guideline recommendations such as the re-
cording of clinical and behavioural risk factors, control of
clinical risk factors and behavioural advice. Data were
abstracted from medical records using a previously devel-
oped paper-based abstraction form. A composite quality
score was created by summing up the number of indica-
tors achieved (9 process and two outcome indicators) di-
vided by the number of applied indicators expressed as
percentages.
Data on practice characteristics and systems were col-
lected by posting questionnaires to the practice team and
by face-to-face or telephone interviews with the leading
General Practitioners (GPs) in each practice. The ques-
tionnaire contained questions to characterize the practice
according to size, location, and number and function of
practice staff. The instrument included also questions
reflecting quality indicators on practice management and
organisation that were partly developed during the EPA-
Cardio project [14] and partly derived from the EPA
practice-management instrument [17]. The practice items
represented organisational processes specific to CVD-
prevention and care (33 items) and more generic practice
management features in the three dimensions ‘informa-
tion process and technology’ (11 items), ‘organisation of
chronic care and prevention’ (19 items) and ‘quality
improvement’ (13 items). The interview guide contained
questions concerning preventive CVD care, e.g. concer-
ning risk assessment, lifestyle counselling and cardiovas-
cular quality improvement activities and projects.
To create practice scores, we aggregated these items
using a factor analysis method for binary variables
(CATPCA) [18]. During this analysis, we identified 27
Figure 1 Data flowchart.
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binary items that were not correlated with each other
and had factor loadings over 0.4 in four dimensions:
‘preventive services’ (PrevServ - 13 items), ‘electronic
medical record’ (EMR - 5 items), ‘chronic care manage-
ment’ (CCM - 6 items) and ‘quality management’ (QM -
3 items). The explained variance was 54%. Scores were
created by summing up the number of ‘yes’- answers
and included in the multilevel analysis and were descrip-
tively presented as percentages of all included items in
each score.
Analyses
We analysed the association between organisational
practice characteristics and the quality of CVRM mea-
sured by a composite performance score, ranging be-
tween zero and eleven (or 0–100%) with higher scores
indicating better quality of CVRM in patients at high
risk of developing CVD. Due to the hierarchical struc-
ture of the data, linear multilevel regression analysis was
applied, which takes into account the non-independence
of patient observations (level 1) nested within practices
(level 2) and these nested within countries (level 3). Sev-
eral models were evaluated starting with an intercept-only
(null) model (M0) without any predictor variables. Vari-
ance partition coefficients in each level were calculated
using the restricted maximum likelihood (REML) method.
This model was used as a reference for comparing the size
of contextual (practice or country) variations of outcomes
in subsequent models. The random-part results of the null
model (M0) are reported together with the corresponding
intra-class correlations (ICC) at the practice and country
level. The differences between the null model and the fol-
lowing models show to which extent the explanatory vari-
ables explain the observed variation in the outcome.
The next model (M1) included only the patient-level
predictors as fixed effects. In contrast, the next two
models included only the practice-level predictors as fixed
effects: M2.1 included only the four practice scores from
CATPCA, M2.2 additionally contained the characteristics
related to practice location and size. The final model (M3)
included a total set of eight potential explanatory variables,
two at the patient level and six at practice level. Explana-
tory variables on country level were not examined. As only
one of the four practice scores showed a significant
association with the outcome, we separated the 13 single
items of this score and calculated the association with the
outcome for each item. By this step we identified 5 items,
calculated a score of these 5 variables and included this
score together with the variables at the patient level, prac-
tice size and location in a sensitivity analysis (M4).
Only patients for whose data on all explanatory variables
on the different levels were available could be included in
the multilevel analysis. A non-responder analysis was per-
formed between those patients included in the final dataset
and those not included because of missing data. The signifi-
cance level was set to 5% (two-sided). Regression coeffi-
cients (r) and corresponding two-sided 95% confidence
intervals (CI) were calculated and considered statistically
significant if the CI excluded zero. Statistical analyses in-
cluding CATPCA were carried out by using SPSS version
20.0 (SPSS Inc., Chicago, IL, USA). The multilevel analyses
were conducted using the procedure PROC MIXED in
SAS version 9.2 (SAS Institute, Cary, NC).
Results
Patient and practice characteristics
A total number of 267 practices and 4,223 patients at high
risk for developing CVD participated in the study. The
mean age of the participants was 66.6 years (SD 9.1) years
and 27.5% were female. The number of participating prac-
tices per country ranged from 22 (Switzerland) to 36
(Slovenia, Spain, the Netherlands and the UK). 31.2% of
the practices were located in large towns (i.e. more than
100,000 inhabitants) and 47.5% had two or more GP full
time equivalents (FTE). The overall achievement was 53.0
for the practice score ‘Preventive Services (PrevServ)’,
81.1% for ‘Electronic Medical Record (EMR)’, 53.3% for
‘Chronic Care Management (CCM)’ and 41.8% for ‘Qua-
lity Management (QM)’ (Table 2). The percentages of the
single-item achievements of these scores are indicated in
Table 3. Scores varied between countries with maximal
scores in the UK and minimal scores in France and
Switzerland (Table 2).
Cardiovascular risk management (CVRM) - performance
The composite quality score across eleven quality indica-
tors was 55.9% (Table 4). Composite scores were highest
in Slovenia (64.1%) and lowest in the Netherlands
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
- High- risk defined by risk calculation with recommended tools according
to national guidelines, e.g. > 20% CVD event risk as calculated by
Framingham
1. Patients with established CVD (including ischemic heart disease,
myocardial infarction, angina pectoris, coronary surgery or
revascularisation procedures, ischaemic stroke, transient ischemic
attack, claudication or peripheral vascular disease)
or 2. Patients with diabetes
- Patients with 3 out of the following 4 risk factors: hypertension,
hypercholesterolemia, smoking, men over 60 years of age
3. Terminal illness, cognitive disorders (e.g. dementia), psychiatric
diseases (e.g. schizophrenia) and lack of language knowledge
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(44.3%) (Table 5). The results of single indicator achieve-
ment are provided in Table 4.
The 3-level linear regression analysis (Table 6) was
based on 3,700 patients (level 1) nested within 240 prac-
tices (level 2) and these nested within nine countries
(level 3). There were up to 72 patients within each prac-
tice and up to 36 practices within each country. There
were no differences according to patient and practice
characteristics between included patients and those ex-
cluded due to missing data. The estimates (regression
coefficients, r) indicate the amount of composite quality-
indicator scores changes (in%) with each increasing unit
of continuous variables (e.g. per 5 year increase for age)
or in comparison to a reference category for categorical
variables (e.g. ‘female’ versus male). Each regression co-
efficient is thereby adjusted for all remaining variables
included in the model and clustering effects (patients
nested in practices and these in countries). At the pa-
tient level, neither gender nor age was associated with
the performance on CVRM. At the practice level, prac-
tice size indicated by full time equivalents (FTE) of GPs
and the practice location had no impact on performance.
The only significant association (r = 1.92; p = 0.0058) was
found for the practice score ‘preventive services’ (Table 6)
reflecting specific structural and organisational processes
of CVD-preventive care (Table 3). The estimate indicates
that the composite quality- indicator score will increase by
1.92% with each additional ‘yes-answer’ of the ‘preventive-
services’ items (1.92 × 13) resulting in a maximum per-
formance increase of 25%. This maximum difference will
be achieved between practices reporting to have none of
these ‘preventive-services specific items implemented and
those reporting the presence of all 13 items included in
the score. The other practice scores had no impact on the
quality of CVRM (Table 3 and Table 6).
The analysis of the 13 single items included in the ‘pre-
ventive services’ score showed that 5 of these items were
positively associated with the CVRM-performance if in-
cluded separately in the sensitivity analysis (M4). These
five practice capabilities included: the ‘PrevServ’-item 2
(Table 3) - integration of lifestyle advice in the electronic
medical record (r = 8.33; p = 0.0006), the ‘PrevServ’-item 7
(Table 3) - use of case-finding methods to identify patients
at risk (r = 6.74; p < 0.0001), the ‘PrevServ’-item 10
(Table 3) - the availability of a register of preventive pros-
pects provided by local organisations (r = 4.79; p = 0.0009),
the ‘PrevServ’-item 11 (Table 3) - continuous medical
education for nurses (r = 6.40; p < 0.0001) and the
‘PrevServ’-item 13 (Table 3) - implementation of a minimal
intervention strategy for stop smoking advice (r = 3.78; p =
0.0322). A score of these 5 items (PrevServ_5) resulted in a
positive association with the CVRM performance (r = 4.28;
p < 0.0001) (Table 7).
The random part results of the null model (M0) indi-
cate that the proportion of variance was greater at the
practice level ICC = 27.4% compared to the country level
Table 2 Practice characteristics and organisational measures
Countries Practices Patients Urban1 FTE2 GP ≥ 2 Practice scores
PrevServ3 EMR4 CCM5 QM6
N N % % % SD7 % SD % SD % SD
Austria 24 285 25.0 0.0 22.1*↓ 16.4 73.3 23.3 42.4 29.5 47.2 31.0
Belgium 24 266 9.1 50.0 35.6*↓ 19.0 85.8 30.3 20.1*↓ 20.3 30.6 40.4
France 29 377 21.4 50,0 24.1*↓ 17.2 86.2 18.6 21.8*↓ 31.2 23.0+↓ 29.7
Germany 26 470 16.7 22.2 28.1*↓ 21.1 70.8 41.3 56.4 35.6 24.4+↓ 27.6
Netherlands 34 467 35.3 23.5 47.1 19.7 95.3*↑ 11.1 71.1*↑ 19.8 23.5*↓ 25.3
Slovenia 36 842 25.0 51.6 76.1*↑ 13.6 54.4*↓ 30.8 41.7+↓ 25.4 30.6 36.8
Spain 36 652 41.7 97.2 89.5*↑ 9.4 99.4*↑ 3.3 88.0*↑ 12.4 64.8*↑ 22.5
Switzerland 22 329 0.0 5.9 28.7*↓ 15.8 50.9*↓ 30.7 9.8*↑ 16.8 10.6*↑ 26.0
UK 36 535 76.5 77.8 87.2*↑ 8.4 100.0*↑ 0.0 94.4*↑ 9.8 98.1*↑ 7.7
Total 267 4223 31.2 47.5 53.0 31.1 81.1 29.2 53.6 36.7 41.8 38.7
1 Urban = Practice in towns with more than 100.000 inhabitants (more than 30.000 for Slovenia).
2 FTE = Full time equivalent.
3 PrevServ = Preventive Services (score: % of ‘yes answers’ from 13 items) (Table 3).
4 EMR = Electronic medical record (score: % of ‘yes answers’ from 5 items) (Table 3).
5 CCM = Chronic Care Management (score: % of ‘yes answers’ from 6 items) (Table 3).
6 QM = Quality Management (score:% of ‘yes answers’ from 3 items) (Table 3).
7 SD = Standard Deviation
* Scores significantly deviating from the mean of all countries (p < 0.0001).
+ Score significantly deviating from the mean of all countries (p = <0.01).
↑ Country score higher than the mean score of all countries.
↓ Country score lower than the mean score of all countries.
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Table 3 Structural and organisational characteristics of practices (N = 267)
No Questionnaire items Yes answers% Factor loads
Preventive services (PrevServ) - 13 Items
1 Is the CVD risk assessment tool integrated with the patient medical record system (e.g. so that
the CVD event risk score is entered directly in to the patient’s medical record)
51.3 0.770
*2 Is CVD risk advice (e.g. about modifiable risk factors such as diet and exercise) integrated with
the patient medical record system?
51.7 0.706
3 Did nurses take part in local/community campaigns or actions on CVD risk prevention (e.g. stop
smoking campaigns, fun-runs etc.)?
27.0 0.654
4 Does the practice use a system for recalling populations at risk for preventive care regarding
cardio- vascular diseases?
52.1 0.601
5 Is there in general a record in the electronic or paper based patient record that the CVD
standardized risk assessment tool has been offered?
48.7 0.577
6 Do you offer regularly two or many consultations to provide advice on patients’ life style? 58.1 0.564
*7 Does the practice use case finding methods to detect patients with cardiovascular risk factors 58.4 0.559
8 Does the practice participate in public health care programmes on life style (physical exercise,
stop smoking)?
59.2 0.553
9 Does the practice use a CVD standardized risk assessment tool? 75.7 0.549
*10 Does the practice have an up-to-date directory of prevention activities/organizations available
locally (e.g. gyms, walking groups, weight-watchers etc.)?
47.6 0.514
*11 Did all nurses attend≥ one training/continuing medical education event on CVD within the last
5 years?
52.1 0.488
12 Did your practice participate in a project concerning cardiovascular risk management the last
2 years?
35.2 0.445
*13 Does the practice have a procedure for smoking cessation (e.g. Minimal Intervention Strategy)? 71.9 0.410
Electronic medical record (EMR) -5 Items
1 Does the practice use a computer-supported patient file system? 74.9 0.831
2 Is the computer used for creating medication prescriptions? 79.4 0.809
3 Do the practice doctors have direct access to medical guidelines (either on paper or electronic)
in their treatment rooms?
92.1 0.666
4 Does the practice have a procedure for the management of patient information in relation to
the review of detailed examination results by the doctor (in terms of outgoing needs)?
76.4 0.633
5 Does the practice have a procedure for the management of patient information in relation to
detailed examination results and the documentation of measures that were taken (e.g., blood
examinations)?
82.8 0.610
Chronic care management (CCM) - 6 Items
1 Does the practice use a system for recalling patients with diabetes? 58.1 0.752
2 Does the practice use a system for recalling patients with cardio vascular diseases? 53.2 0.705
3 Does the practice use a system for recalling patients with hypertension? 48.3 0.642
4 Did the practice participate in cardiovascular quality improvement projects? 56.9 0.504
5 Does the practice use a system for recalling populations at risk for preventive care regarding
influenza?
54.3 0.499
6 Did the practice have a team meeting about quality improvement relating to CVD at least once
in the last 15 months?
50.6 0.480
Quality management (QM) - 3 Items
1 Does the practice produce a quality report? 34.5 0.711
2 Has the practice undertaken at least one clinical audit in the last 12 months? 53.2 0.703
3 Does the practice have a critical incident register? 37.8 0.569
* Items that are separately significantly associated with composite quality score.
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ICC = 7.1%. The best model fit was achieved by the last
regression model (Table 7). The variables included
explained 21.1% of the variation between practices.
Discussion
We investigated the association between structural and
organisational practice characteristics and the quality of
cardiovascular risk management (CVRM) provided to
patients at high risk for developing CVD. Our study has
two main findings: Firstly, performance across the com-
posite quality measure of eleven indicators of CVRM
revealed an achievement of only 55.9%. The composite
score included indicators of recommended preventive
procedures related to the recording of clinical and be-
havioural risk factors and behavioural advice and also
outcomes, i.e. the control of clinical risk factors (blood
pressure and cholesterol). Secondly, we found a positive
association between CVD-prevention related organisa-
tional and functional capabilities of primary care prac-
tices and the quality of CVRM provided to patients at
high risk of developing CVD in routine primary care set-
tings across different health care systems in Europe. As
differences between primary care practices were larger
within rather than between countries, these findings sug-
gest that practice characteristics do explicitly have im-
pact on the quality of cardiovascular risk management in
primary care.
Composite measures of quality indicators were used in
previous studies to assess quality of care for multiple con-
ditions in primary care [19,20]. The result of the compos-
ite measure for recommended chronic care (56.1%) before
implementation of quality improvement approaches such
as the QOF was quite similar to the composite quality
measure found in our study [19,21].
There are many ways to describe practice characteris-
tics and their linkage to quality of care in various set-
tings resulting in heterogeneous findings [11-13,22-27].
In our study, we had included practices from different
health care systems with a wide variation concerning the
use of information technology and the implementation
of recommended procedures of CVRM. We described
practice capabilities using four scores of practice charac-
teristics related to generic quality-management aspects,
chronic care management, the use of EMR-systems and
specific CVD-preventive care features, items of which
were derived from EPA instruments [14,15,17].
Table 4 Quality indicators included in the composite outcome measure (N = 4223)
Quality indicators Achieved%
1 Record of smoking status in the last 15 months (process indicator) 78.3
2 Record of physical activity in the last 15 months (process indicator) 46.2
3 Record of Body Mass Index (BMI) or weight in the last 15 months (process indicator) 67.0
4 Record of blood pressure in the last 15 months (process indicator) 91.6
5 Record of cholesterol in the last 15 months (process indicator) 81.3
6 Record of blood glucose (random or fasting) in the last 15 months (process indicator) 73.7
7 Advice for smokers to quit smoking in the last 15 months (process indicator) 68.1
8 Advice for regular physical activity in the last 15 months (process indicator) 38.6
9 Advice for healthy diet in the last 15 months (process indicator) 46.1
10 Control of blood pressure level (mean blood pressure level of maximal 3 measures≤ 140/90) (intermediate outcome indicator) 46.7
11 Control of total cholesterol level (≤ 5 mmol/l) (intermediate outcome indicator) 28.4
Outcome measure: Quality score
Percentage of overall achievement across 11 quality indicators (0-100%) 55.9
Table 5 Practice performance scores on cardiovascular
risk management (CVRM) (N = 4,223 individuals; 267
practices)
Countries Composite quality score*
Achievement% SD Deviance from the
overall mean (p)**
Austria 56,5 20,5 ⇆
Belgium 59,1 19,0 ↑ p = 0.006)
France 62,3 16,5 ↑ (p < 0.0001)
Germany 53,5 18,4 ↓ (p = 0.006)
Netherlands 44,3 24,5 ↓ (p < 0.0001)
Slovenia 64,1 20,8 ↑ (p < 0.0001)
Spain 51,8 25,0 ↓ (p < 0.0001)
Switzerland 48,4 20,8 ↓ (p < 0.0001)
UK 58,4 21,5 ↑ (p = 0.006)
Total 55,9 22,2
⇆ Country score shows no deviance from the mean score of all countries.
↑ Country score higher than the mean score of all countries.
↓ Country score lower than the mean score of all countries.
* Composite quality score = Percentage of overall achievement across 11
quality indicators.
** p-values calculated by t-test.
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Only one score, the preventive-services score that
contained CVD-prevention related organisational and
functional practice features in a more specific way, was
significantly associated with clinical performance on
CVRM. Within these characteristics (Table 3) five prac-
tice characteristics were sparately associated with higher
quality of CVRM. These characteristics were related to
the integration of lifestyle advice procedures in the elec-
tronic medical record system, the implementation of
case-finding methods to identify patients at risk, the
provision of a register of preventive prospects of local
organisations, continuous medical education for nurses
and the implementation of a minimal intervention strat-
egy for stop smoking advice.
Most previous studies investigating the relationship
between practice characteristics and quality of health
care have focused on the delivery of chronic care rather
than on prevention. The Chronic Care Model (CCM) is
a widely adopted framework to enhance evidence based
chronic care in primary care [28] and elements of the
CCM have been associated with improved quality of care
and patient outcomes [22,29,30]. A study in two U.S.
managed care organisations found that only few practice
characteristics were related to the quality of care such as
multi-site practices and those with an intermediate num-
ber of member physicians [11]. Other characteristics
such as financial incentives or the use of EHR without
determining functional capacities had no effect on qual-
ity measures [11].
Holmboe et al. used a measurement tool that assessed
the presence of practice structure and care process ele-
ments to qualify primary care practices as ‘medical
homes’, a widely accepted framework of patient-centred
care [13]. They did not find an association between ‘suc-
cessful’ practice systems according to these measure-
ments and the quality of care for multiple diseases and
conditions [13]. It is assumed that practices in study set-
tings such as managed care organisations with high
quality standards may not significantly differ from each
other [11]. This may explain why we found associations
of practice characteristics and quality of care in a Euro-
pean sample with large variation between practices,
whereas another study in practices that were granted at
the highest attainable level of medical home recognition
by the National Committee for Quality Assurance
(NCQA) found no relationship between systems and
performance measures [31]. The CCM-score in our
study was not associated with the quality outcome. A
possible reason therefore may be that focussing on
chronic care management does not automatically imply
the delivery of high quality preventive services for pa-
tients at risk without an established chronic disease [32].
In fact, promoting the delivery chronic care management
by providing financial incentives may rather lead to the
disregard of other patient groups and services [33].
Other studies with a broader focus on health care in-
cluding preventive services have found only few relation-
ships between practice characteristics and clinical
performance measures [12,13,34]: It has been argued
that general quality assurance processes implemented in
practices such as the regular collecting of data for audit
Table 6 Association of explanatory variables with the
composite quality score (N = 3,700 individuals within 240
general practices within 9 countries)
Estimate [95% CI] P value
Individual level
Age (per 5-year) −0.53 [−1.43; 0.37] 0.2503
Gender: female −0.99 [−2.33; 0.33] 0.1408
Practice level
FTE GP ≥ 21 2.07 [−1.96; 6.10] 0.3134
Practice location: urban2 0.45 [−3.99; 4.89] 0.8429
Practice score ‘PrevServ’3 1.92 [0.56; 3.38] 0.0058
Practice score ‘EMR’4 0.06 [−2.34; 2.46] 0.9593
Practice score ‘CCM’5 −0.88 [−2.22; 0.46] 0.2001
Practice score ‘QM’6 −0.21 [−2.11; 1.68] 0.8245
1 FTE = Full time equivalent.
2 Urban: Practice location in town > 100,000 inhabitants (> 30,000 in Slovenia).
3 PrevServ = Preventive Services (score: % of ‘yes answers’ from 13 items)
(Table 3).
4 EMR = Electronic medical record (score: % of ‘yes answers’ from 5 items)
(Table 3).
5 CCM = Chronic Care Management (score: % of ‘yes answers’ from 6 items)
(Table 3).
6 QM = Quality Management (score: % of ‘yes answers’ from 3 items) (Table 3).
Table 7 Association of explanatory variables with the
composite quality score (N = 3,700 individuals within 240
general practices within 9 countries)
Estimate [95% CI] P value
Individual level
Age (per 5-year) −0.52 [−1.42; 0.38] 0.2567
Gender: female −0.99 [−2.31; 0.35] 0.1488
Practice level
FTE GP ≥ 21 1.60 [−2.12; 5.33] 0.3983
Practice location: urban2 0.13 [−3.36; 3.62] 0.9421
Practice score ‘PrevServ_53 4.28 [2.59; 5.97] <0.0001
1 FTE = Full time equivalent.
2 Urban: Practice location in town > 100,000 inhabitants (> 30,000 in Slovenia).
3 PrevServ_5 = Score of the number of ‘yes answers’ from the following items
(Table 3):
Item 2: Is CVD risk advice (e.g. about modifiable risk factors such as diet and
exercise) integrated with the patient medical record system?
Item 7: Does the practice use case finding methods to detect patients with
cardiovascular risk factors?
Item 10: Does the practice have an up-to-date directory of prevention
activities/organizations available locally (e.g. gyms, walking groups,
weight-watchers etc.)?
Item 11: Did all nurses attend ≥ one training/continuing medical education
event on CVD within the last 5 years?
Item 13: Does the practice have a procedure for smoking cessation (e.g.
Minimal Intervention Strategy)?
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purposes have no impact on quality of care [12]. This re-
sult is comparable to our study were the QM-score was
not associated with better outcomes. In line with our
study results, the presence of an electronic medical rec-
ord system (EMR) was not associated with quality of
care but rather the availability and the use of specific
EHR-features [13,34]. It was reported that the assess-
ment of practice characteristics must consider more
than practice structure, even the practice staff working
in the practice system, their patients and the crucial in-
teractions among the system, physicians, patients and
community resources [13].
It is notable that the five practice capabilities associ-
ated with a higher quality of CVRM in our study were
mainly related to the identification of patients at risk
and lifestyle management procedures. The identification
of patients at risk and lifestyle management are key
components of cardiovascular prevention [35], time con-
suming and generally not reimbursed in primary care
[36]. The delivery of effective preventive care services
may therefore require more support from health care
systems [36,37].
Strengths and limitations
We used multilevel modelling to identify predictors of the
quality of CVRM in one model that adjusted for the hier-
archical structure of our data and for the remaining vari-
ables included in the model. Hierarchical models combine
information across units to produce accurate and well cal-
ibrated prediction of outcomes [38]. This analytical ap-
proach can also be used to describe the amount of
variation at each level that makes it possible to separate
practice variation from country (health system) influence.
We used a medical record audit to measure performance
on CVRM that provides valid data but is also dependent
on the quality of documentation. The practice measures
were self-reported by physicians, however, it has been
demonstrated that lead physicians tend to underestimate
the features they have in their practices [39].
In some countries it was difficult to enrol 36 practices,
as intended in the power analysis, and that may affect
the generalisabilty of our results. The patient sample in-
cluded a greater proportion of men due to the inclusion
criterion ‘men over 60 years’ as one of four risk factors
(Table 1) that were used for inclusion. However, the re-
sults of the multilevel analyses were controlled for gen-
der influences. The multilevel analyses led to a decrease
of the total number of cases due to missing data, as we
conducted a complete cases analysis. However, we made
sure that both samples did not differ between each other
according to patient and practice characteristics.
The cross-sectional design of our study does not allow
causal attribution of performance to structural and or-
ganisational practice characteristics. However, because of
the international character of the study, a larger external
validity can be expected.
Conclusions
Our study results suggest that the quality of cardiovascular
risk management in individuals at high risk for developing
CVD is improvable with mean indicator achievement of
only 55,9% and with a greater variation in practice scores
within rather than between countries. Quality improve-
ment is associated with practice capabilities related to the
identification of patients at risk (risk assessment), continu-
ous education for nurses and lifestyle management proce-
dures integrated in to the electronic medical record
system. The implementation of these preventive services
in primary routine care may require health care system
support.
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